Abstract
BACKGROUND Patients undergoing liver transplantation can develop posterior reversible encephalopathy syndrome (PRES) and acute heart failure (HF) in the postoperative period. But PRES with HF caused by tacrolimus has rarely been described. CASE SUMMAR A 40-year-old female patient who had a normal preoperative cardiac and neural evaluation developed PRES with acute heart failure tacrolimus-induced after liver transplantation. The challenges associated with both diagnosis and management in the setting of a newly implanted graft are discussed. CONCLUSION Tacrolimus can induce neurotoxicity and then cardiac toxicity. Magnetic resonance imaging, echocardiography, and increased brain natriuretic peptide may be predictive of post-operative PRES with acute heart failure. Further investigations are necessary to verify this finding.
Author supplied keywords
Cite
CITATION STYLE
Liu, J. F., Shen, T., & Zhang, Y. T. (2020). Posterior reversible encephalopathy syndrome and heart failure tacrolimus-induced after liver transplantation: A case report. World Journal of Clinical Cases, 8(13), 2870–2875. https://doi.org/10.12998/wjcc.v8.i13.2870
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.